These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8146043)

  • 1. [Distribution of phospholipids in platelet membranes and platelet factor 3 availability in patients with chronic kidney failure].
    Krawczyk W; Dmoszyńska A; Ledwozyw A
    Pol Arch Med Wewn; 1993 Dec; 90(6):409-15. PubMed ID: 8146043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Distribution of platelet membrane phospholipids in patients chronically hemodialyzed using cuprophane and cellulose acetate membranes].
    Krawczyk W; Marczewski K; Ledwozyw A; Dmoszyńska A
    Pol Arch Med Wewn; 1994 Jul; 92(1):41-6. PubMed ID: 7971476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of human recombinant erythropoietin on distribution of membrane phospholipids in blood platelets of patients with uremia treated with repeated hemodialysis].
    Krawczyk W; Ledwozyw A; Dmoszyńska A; Krzywicka A; Rózyc P
    Pol Arch Med Wewn; 1997 Feb; 97(2):120-5. PubMed ID: 9312760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of platelet hemostasis in patients with chronic renal failure].
    Krawczyk W; Dmoszyńska A; Sokołowska B
    Wiad Lek; 1994 Feb; 47(3-4):93-9. PubMed ID: 7975649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Change of platelet function after the beginning of repeated hemodialysis treatment in patients with uremia].
    Krawczyk W; Dmoszyńska A; Marczewski K; Rózyc P
    Pol Arch Med Wewn; 1994 Dec; 92(6):483-8. PubMed ID: 7716051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The influence of recombinant human erythropoietin on platelet phospholipid fatty acid composition in patients on long term hemodialysis].
    Krawczyk W; Dmoszyńska A; Ledwozyw A
    Pol Merkur Lekarski; 1996 Dec; 1(6):394-7. PubMed ID: 9273229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Factors influencing platelet procoagulant activity in type II diabetic patients. The role of sodium-proton exchange].
    Telejko B; Kinalska I; Stelmach H; Tomasiak M
    Przegl Lek; 2003; 60(9):553-6. PubMed ID: 15065331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet factor 3 in normal subjects and patients with renal failure.
    Rabiner SF; Hrodek O
    J Clin Invest; 1968 Apr; 47(4):901-12. PubMed ID: 5641625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinico-haematological profile of isolated PF3 availability defect: therapeutic potential of soya bean--a pilot study.
    Saxena R; Choudhry VP; Mishra DK; Kashyap R; Mohanty S; Mahapatra M; Dwivedi SN
    Eur J Haematol; 1999 May; 62(5):327-31. PubMed ID: 10359061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Local microviscosity of platelet membranes from patients with chronic renal failure on hemodialysis].
    Rud'ko IA; Chebotarev VN; Kubatiev AA
    Patol Fiziol Eksp Ter; 1994; (1):20-2. PubMed ID: 8183585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of human recombinant erythropoietin (rhuEPO) on platelet phospholipids in chronically hemodialysed].
    Krawczyk W; Dmoszyńska A; Ledwozyw A; Soroka-Wojtaszko M
    Acta Haematol Pol; 1993; 24(4):327-31. PubMed ID: 8303978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The composition of fatty acids in individual classes of blood platelet phospholipids of patients with uremia].
    Krawczyk W; Dmoszyńska A; Ledwozyw A
    Pol Arch Med Wewn; 1993 May; 89(5):377-84. PubMed ID: 8367371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo effects of adrenaline and phentolamine on platelet function.
    Ponari O; Civardi E; Megha A; Pini M; Poti' R; Dettori AG
    Thromb Haemost; 1978 Oct; 40(2):428-37. PubMed ID: 734640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of hemodialysis on expression of glycoprotein lb platelets reactivity in patients with the end stage renal failure].
    Brzósko S; Hryszko T; Zak J; Wysocka J; Małyszko J; Myśliwiec M
    Przegl Lek; 2002; 59(10):823-5. PubMed ID: 12632921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet sodium-proton exchanger and phospholipid-dependent procoagulant activity in patients with type 2 diabetes.
    Telejko B; Tomasiak M; Stelmach H; Kinalska I
    Metabolism; 2003 Jan; 52(1):102-6. PubMed ID: 12524669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hemodialysis on platelet function in end-stage renal disease Egyptian patients using in vitro closure time test (PFA-100 analyzer).
    Mekawy MA; Habashy DM; Abd El-Mohsen WA
    Platelets; 2015; 26(5):443-7. PubMed ID: 24955720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet functions in dysproteinaemia.
    Kasturi J; Saraya AK
    Acta Haematol; 1978; 59(2):104-13. PubMed ID: 415475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human erythropoietin improves the blood platelet phospholipid composition in chronically hemodialyzed patients.
    Krawczyk W; Dmoszyńska A; Marczewski K; Ledwozyw A
    Exp Nephrol; 1995; 3(4):265-6. PubMed ID: 8590040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Location of phosphatidylethanolamine and phosphatidylserine in the human platelet plasma membrane.
    Schick PK; Kurica KB; Chacko GK
    J Clin Invest; 1976 May; 57(5):1221-6. PubMed ID: 1262468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of platelet factor-3 activation after incubation of platelet-rich plasma with kaolin in the rat.
    Clerck FD; Goossens J; Beerens M
    Experientia; 1976 Dec; 32(12):1602-3. PubMed ID: 1021463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.